Futura Medical and Haleon partner to commercialise Eroxon gel in US -  Medical Device Network

Futura Medical and Haleon partner to commercialise Eroxon gel in US - Medical Device Network

4.5
(364)
Écrire un avis
Plus
€ 20.99
Ajouter au panier
En Stock
Description

UK-based Futura Medical has signed a deal with Haleon to commercialise its OTC erectile dysfunction gel, Eroxon, in the US.

Top Clinical Research Informer Pharma Packaging Gene Silencing

Futura Medical gains regulatory green light for Eroxon in Saudi

Yiyi Chen on LinkedIn: #eroxon

Futura Medical PLC (LON:FUM) Share Price

Futura Medical Announces Agreement With Haleon To Commercialise

Trinity Delta Significant achievements position MED3000 for

Futura Medical PLC (LON:FUM) Share Price

Eroxon, First Over-The-Counter Erectile Dysfunction Gel, Gets FDA

Eroxon, First Over-The-Counter Erectile Dysfunction Gel, Gets FDA

Futura Medical PLC (LON:FUM) Share Price

Futura Medical on LinkedIn: #eroxon #futuramedical #breakthrough

Futura Medical on path to profitability with commercial traction